Sintx Technologies Inc 's ability to collect accounts receivable sequentially worsen to 5.37, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Sintx Technologies Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 68 days, from 67 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 451 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2303 to 3147.

What is Receivable Turnover Ratio?
What is Sintx Technologies Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SINT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	239.18 %	275.26 %	-9.18 %	-64.71 %	-77.65 %
Y / Y Revenue Change	199.34 %	2.98 %	-46.49 %	-73.97 %	-82.42 %
Receivable Turnover Ratio (TTM)	5.37	5.42	8.28	9.96	10.2
SINT's Total Ranking	# 3147	# 2303	# 1169	# 2920	# 2644
Accounts Receivable average collection period days	68	67	44	37	36
Seq. Receivable Change	-9.62 %	104.49 %	48.33 %	23.71 %	0 %
Seq. Revenue Change	18.95 %	31.03 %	39.42 %	37.75 %	-59.08 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 163
Healthcare Sector	# 452
Overall Market	# 3147

Receivable Turnover Ratio Statistics
High	Average	Low
0.6	0.25	0.01
(Mar 31 2018)		(Jun 30 2021)

SINT Company Profile • Back to SINT Efficiency Comparisons • Compare SINT Receivables Turnover Ratio to its Competitors

Financial Statements
Sintx Technologies Inc 's Accounts Receivable	$ 0 Millions	Visit SINT's Balance sheet
Sintx Technologies Inc 's Sales TTM	$ 1 Millions	Visit SINT's Income Statement
Sources of SINT's Revenues		Visit SINT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SINT's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SINT's Growth Rates	SINT's Roa	SINT's Inventory Turnover Ratio	SINT's Dividend Comparisons
SINT's Profitability Ratios	SINT's Roi	SINT's Asset Turnover Ratio	SINT's Dividend Growth
SINT's Valuation Ratios	SINT's Roe	SINT's Financial Strength Ratios	SINT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
The Oncology Institute Inc	9.57	$ 587.244 Millions	$ 61.364 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biofrontera Inc	8.88	$ 45.956 Millions	$ 5.178 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Sanara Medtech Inc	8.76	$ 110.116 Millions	$ 12.568 Millions
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions

Date modified: 2026-09-05T00:15:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.